Actualités Shoal Point Energy Ltd - SHP | Actions Canadian Securities Exchange

Outils de qualité professionnelle, pour des investisseurs individuels.

Nominate a Non-professional Caregiver for International BRAVE Awards through June 30

Nominate a Non-professional Caregiver for International BRAVE Awards through June 30 PR Newswire DUBLIN, June 14, 2013 DUBLIN, June 14, 2013...

Shire to Present at the Goldman Sachs 34th Annual Global Healthcare Conference

Shire to Present at the Goldman Sachs 34th Annual Global Healthcare Conference PR Newswire LEXINGTON, Massachusetts, June 11, 2013 LEXINGTON...

Shire Settles Patent Infringement Lawsuit Against Teva Concerning INTUNIV®

Shire Settles Patent Infringement Lawsuit Against Teva Concerning INTUNIV® PR Newswire PHILADELPHIA, May 31, 2013 PHILADELPHIA, May 31, 2013...

Shire to Present at the Deutsche Bank 38th Annual Health Care Conference

Shire to Present at the Deutsche Bank 38th Annual Health Care Conference PR Newswire LEXINGTON, Massachusetts, May 30, 2013 LEXINGTON...

Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting

Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting PR...

Shire Wins Patent Trial Against Watson Concerning LIALDA®

Shire Wins Patent Trial Against Watson Concerning LIALDA® PR Newswire PHILADELPHIA, May 9, 2013 PHILADELPHIA, May 9, 2013 /PRNewswire/ -- Shire...

New Chief Executive Reports Q1 Results and Sets out Strategy for Growth

New Chief Executive Reports Q1 Results and Sets out Strategy for Growth PR Newswire DUBLIN, May 2, 2013 DUBLIN, May 2, 2013 /PRNewswire/...

Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII) Now Approved in the US for Maintenance Treatment in Children and Adol...

Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII) Now Approved in the US for Maintenance Treatment in Children and Adolescents with...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Shoal Point Energy Ltd (SHP)

Outils de qualité professionnelle, pour des investisseurs individuels.

SHP Actualités

Nominate a Non-professional Caregiver for International BRAVE Awards through June 30

Shire to Present at the Goldman Sachs 34th Annual Global Healthcare Conference

Shire Settles Patent Infringement Lawsuit Against Teva Concerning INTUNIV®

Shire to Present at the Deutsche Bank 38th Annual Health Care Conference

Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting

Shire Wins Patent Trial Against Watson Concerning LIALDA®

New Chief Executive Reports Q1 Results and Sets out Strategy for Growth

Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII) Now Approved in the US for Maintenance Treatment in Children and Adol...

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Shoal Point Energy Ltd (SHP) Actualités

Shoal Point Energy Ltd (SHP)

Outils de qualité professionnelle, pour des investisseurs individuels.

SHP Actualités

Nominate a Non-professional Caregiver for International BRAVE Awards through June 30

Shire to Present at the Goldman Sachs 34th Annual Global Healthcare Conference

Shire Settles Patent Infringement Lawsuit Against Teva Concerning INTUNIV®

Shire to Present at the Deutsche Bank 38th Annual Health Care Conference

Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting

Shire Wins Patent Trial Against Watson Concerning LIALDA®

New Chief Executive Reports Q1 Results and Sets out Strategy for Growth

Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII) Now Approved in the US for Maintenance Treatment in Children and Adol...

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application